Durable control of locally recurrent renal cell carcinoma using stereotactic body radiotherapy
- 8 September 2014
- journal article
- case report
- Published by BMJ in BMJ Case Reports
- Vol. 2014
Abstract
Renal cell carcinoma (RCC) is generally poorly responsive to conventional radiation doses, and patients with inoperable local recurrence have limited therapeutic options. Stereotactic body radiotherapy (SBRT) is an increasingly available technology that allows delivery of a radiation schedule providing doses far more biologically effective against cancer cells than conventional radiotherapy. We present a case where durable disease control was achieved using SBRT in a patient with inoperable locally recurrent RCC who presented 18 years from original nephrectomy. The patient remains asymptomatic with no evidence of active disease 30 months following SBRT. This case highlights the need to reconsider the role of therapies with continuing advances in technology.Keywords
This publication has 16 references indexed in Scilit:
- Single-fraction stereotactic body radiotherapy for spinal metastases from renal cell carcinomaJournal of Neurosurgery: Spine, 2012
- A systematic review of stereotactic radiotherapy ablation for primary renal cell carcinomaBJU International, 2012
- Stereotactic body radiation therapy and 3-dimensional conformal radiotherapy for stage I non-small cell lung cancer: A pooled analysis of biological equivalent dose and local controlPractical Radiation Oncology, 2012
- Outcome Predictors of Gamma Knife Radiosurgery for Renal Cell Carcinoma MetastasesNeurosurgery, 2011
- 21 years of Biologically Effective DoseBritish Journal of Radiology, 2010
- An Overview of Hypofractionation and Introduction to This Issue of Seminars in Radiation OncologySeminars in Radiation Oncology, 2008
- Renal cell carcinoma local recurrences: impact of surgical treatment and concomitant metastasis on survivalBJU International, 2006
- Radiosurgery in patients with renal cell carcinoma metastasis to the brain: long-term outcomes and prognostic factors influencing survival and local tumor controlJournal of Neurosurgery, 2003
- Postoperative radiotherapy in stage II and III renal adenocarcinoma. A randomized trial by the Copenhagen renal cancer study groupInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1987
- Preoperative Irradiation in the Treatment of Renal AdenocarcinomaScandinavian Journal of Urology and Nephrology, 1977